Navigation Links
Computer simulations help explain why HIV cure remains elusive
Date:3/15/2012

Bethesda, MD March 15, 2012 -- A new research report appearing in the March 2012 issue of the journal Genetics shows why the development of a cure and new treatments for HIV has been so difficult. In the report, an Australian scientist explains how he used computer simulations to discover that a population starting from a single human immunodeficiency virus can evolve fast enough to escape immune defenses. These results are novel because the discovery runs counter to the commonly held belief that evolution under these circumstances is very slow.

"I believe the search for a cure for AIDS has failed so far because we do not fully understand how HIV evolves," said Jack da Silva, Ph.D., author of the study from the School of Molecular and Biomedical Science at the University of Adelaide in Adelaide, Australia. "Further insight into the precise genetic mechanisms by which the virus manages to so readily adapt to all the challenges we throw at it will, hopefully, lead to novel strategies for vaccines and other control measures."

To make this discovery, da Silva used computer simulation to determine whether, under realistic conditions, the virus could evolve as rapidly as had been reported if the virus population started from a single individual virus. This was done by constructing a model of the virus population and then simulating the killing of virus-infected cells by the immune system, along with mutation, recombination and random genetic changes, due to a small population size, affecting viral genes. Results showed that for realistic rates of cell killing, mutation and recombination, and a realistic population size, that the virus could evolve very rapidly even if the initial population size is one.

"A cure for HIV/AIDS has been elusive, and this report sheds light on the reason," said Mark Johnston, Ph.D., Editor-in-Chief of the journal Genetics. "Now that we know HIV rapidly evolves, even when its population size is small, we may be able to interfere with its ability to evolve so we can get the most out of the treatments that are developed."


'/>"/>

Contact: Phyllis Edelman
pedelman@genetics-gsa.org
301-351-0896
Genetics Society of America
Source:Eurekalert

Related biology news :

1. ORNL completes first phase of Titan supercomputer transition
2. Schizophrenia patients ability to monitor reality may be helped by computerized training
3. Computer sleuthing helps unravel RNAs role in cellular function
4. Worlds greenest supercomputer heads to Melbourne to boost health research
5. Computer order entry systems reduce preventable adverse drug events
6. From field to biorefinery: Computer model optimizes biofuel operations
7. PNNLs Olympus supercomputer advances science, saves energy
8. Computerized tool takes a bite out of traditional apple testing
9. Supercomputer seeks way to mimic mollusk shell
10. TV viewing poses greater risk than computer use for cardiovascular disease
11. Magnifying research: Scientists team together to upgrade supercomputer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/18/2018)... ... December 18, 2018 , ... CP Merritt is a national champion Arabian horse ... years however in 2006, he had a medical setback that caused him to limp ... suffered from cartilage degeneration in his right rear fetlock. Such an injury could ...
(Date:12/13/2018)... ... December 12, 2018 , ... ... one of the firm’s prominent Expert Consultants, was recently honored by the American ... leaders who are working in pharmaceutical science, technology, engineering, or education and whose ...
(Date:12/13/2018)... LAKELAND, Fla. (PRWEB) , ... December 12, 2018 , ... ... and preventing the growing problem of drowsy and distracted driving, one of the main ... project, under the guidance of Dr. Kanwal Gagneja , assistant professor of computer ...
Breaking Biology News(10 mins):
(Date:1/8/2019)... ... January 07, 2019 , ... ... members into Noninvasix. This represents the second investment AngelMD has made into Noninvasix ... morbidity, Noninvasix is developing a patient monitor to directly, accurately, and noninvasively measure ...
(Date:1/7/2019)... ... 07, 2019 , ... Kainos Medicine Inc. today announced that ... code-named "KM-819." KM-819 is an orally active small molecule that is a ... , This Phase 1 randomized, double-blind, placebo-controlled dose-escalation study was to evaluate ...
(Date:1/4/2019)... ... January 01, 2019 , ... uBiome, the ... World Economic Forum Annual Meeting January 22-25, 2019 held in Davos-Klosters, Switzerland following ... World Economic Forum Annual Meeting brings together leaders of global society–the heads and ...
(Date:1/4/2019)... ... January 03, 2019 , ... ... of oncolytic virus-based immunotherapies for cancer, today announced the founding of a scientific ... critical input and guidance from key leaders in the Immuno-Oncology field. The founding ...
Breaking Biology Technology: